Pier Capital, LLC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 154 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2014. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
Pier Capital, LLC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q4 2014$6,557,000
-4.7%
194,756
-0.8%
0.97%
-11.5%
Q3 2014$6,877,000
+5.4%
196,369
-1.1%
1.10%
+18.8%
Q2 2014$6,527,000
-18.4%
198,620
-8.5%
0.93%
-10.1%
Q1 2014$7,999,000
-4.5%
217,001
-0.6%
1.03%
-7.8%
Q4 2013$8,376,000
+10.7%
218,228
-20.9%
1.12%
+4.7%
Q3 2013$7,563,000276,0281.07%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2014
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders